AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $890 | -20.9% | 44 | 0.0% | 0.00% | – |
Q2 2023 | $1,125 | +99.1% | 44 | +131.6% | 0.00% | – |
Q1 2023 | $565 | +9.9% | 19 | 0.0% | 0.00% | – |
Q4 2022 | $514 | -48.6% | 19 | -67.2% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 58 | +45.0% | 0.00% | – |
Q2 2022 | $1,000 | -92.9% | 40 | -90.4% | 0.00% | – |
Q1 2022 | $14,000 | 0.0% | 415 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | +7.7% | 415 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | -7.1% | 415 | +5.3% | 0.00% | – |
Q2 2021 | $14,000 | -100.0% | 394 | -64.6% | 0.00% | – |
Q1 2021 | $48,638,000 | +270111.1% | 1,112 | +182.2% | 0.00% | – |
Q4 2020 | $18,000 | +28.6% | 394 | -3.7% | 0.00% | – |
Q3 2020 | $14,000 | +16.7% | 409 | +3.8% | 0.00% | – |
Q2 2020 | $12,000 | +20.0% | 394 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | -23.1% | 394 | 0.0% | 0.00% | – |
Q4 2019 | $13,000 | -68.3% | 394 | -64.4% | 0.00% | -100.0% |
Q3 2019 | $41,000 | -35.9% | 1,108 | -25.3% | 0.00% | -50.0% |
Q2 2019 | $64,000 | -23.8% | 1,483 | +21.4% | 0.00% | -50.0% |
Q3 2018 | $84,000 | – | 1,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
S.A. Mason LLC | 6,527 | $299,000 | 0.25% |